| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.966 | 0.002 | 0.966 | Aldehyde oxidase inhibitor | 0.686 0.009 CID_31507 | ||
| 0.805 | 0.003 | 0.805 | Vasodilator | 0.683 0.004 CID_31507 | ||
| 0.603 | 0.016 | 0.603 | Vasodilator, peripheral | 0.195 0.182 CID_31507 | ||
| 0.551 | 0.005 | 0.551 | Pyruvate kinase inhibitor | 0.27 0.056 CID_31507 | ||
| 0.546 | 0.002 | 0.546 | Myeloperoxidase inhibitor | 0.197 0.005 CID_31507 | ||
| 0.548 | 0.022 | 0.566 | Streptokinase A inhibitor | 0.566 0.02 CID_31507 | CID_31507 | |
| 0.538 | 0.023 | 0.538 | Angiogenesis inhibitor | 0.424 0.046 CID_31507 | ||
| 0.5 | 0.01 | 0.5 | Peroxidase inhibitor | 0.197 0.06 CID_31507 | ||
| 0.477 | 0.033 | 0.477 | GABA C receptor rho-3 antagonist | 0.415 0.055 CID_31507 | ||
| 0.469 | 0.048 | 0.469 | 15-Lipoxygenase inhibitor | |||
| 0.429 | 0.013 | 0.429 | Cyclic AMP phosphodiesterase inhibitor | 0.254 0.062 CID_31507 | ||
| 0.396 | 0.031 | 0.396 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.362 | 0.013 | 0.362 | DNA methyltransferase I inhibitor | 0.144 0.11 CID_31507 | ||
| 0.446 | 0.097 | 0.549 | Alpha-glucosidase inhibitor | 0.549 0.066 CID_31507 | CID_31507 | |
| 0.387 | 0.043 | 0.387 | Spasmolytic | |||
| 0.347 | 0.017 | 0.347 | DNA methylase inhibitor | |||
| 0.326 | 0.011 | 0.326 | Aurora-A kinase inhibitor | 0.246 0.018 CID_31507 | ||
| 0.303 | 0.021 | 0.303 | Vascular endothelial growth factor antagonist | 0.242 0.03 CID_31507 | ||
| 0.386 | 0.115 | 0.515 | Transcription factor inhibitor | 0.515 0.07 CID_31507 | CID_31507 | |
| 0.331 | 0.09 | 0.331 | Prostaglandin dehydrogenase inhibitor | |||
| 0.283 | 0.043 | 0.283 | Tyrosine 3 hydroxylase inhibitor | 0.261 0.058 CID_31507 | ||
| 0.296 | 0.058 | 0.296 | Cardiotonic | |||
| 0.235 | 0.028 | 0.235 | Vascular endothelial growth factor 2 antagonist | 0.203 0.034 CID_31507 | ||
| 0.275 | 0.069 | 0.275 | Aryl hydrocarbon receptor agonist | |||
| 0.216 | 0.023 | 0.216 | Vascular endothelial growth factor 1 antagonist | 0.133 0.048 CID_31507 | ||
| 0.287 | 0.098 | 0.287 | Antithrombotic | |||
| 0.199 | 0.015 | 0.199 | Epidermal growth factor antagonist | 0.114 0.036 CID_31507 | ||
| 0.214 | 0.034 | 0.214 | Cyclin-dependent kinase inhibitor | 0.16 0.051 CID_31507 | ||
| 0.319 | 0.145 | 0.355 | 5 Hydroxytryptamine release inhibitor | 0.355 0.111 CID_31507 | CID_31507 | |
| 0.181 | 0.008 | 0.181 | Alcohol oxidase inhibitor | 0.102 0.018 CID_31507 | ||
| 0.199 | 0.029 | 0.199 | MAO A inhibitor | 0.141 0.044 CID_31507 | ||
| 0.174 | 0.005 | 0.174 | Maillard reaction inhibitor | |||
| 0.172 | 0.003 | 0.172 | Diamine oxidase inhibitor | 0.069 0.007 CID_31507 | ||
| 0.336 | 0.167 | 0.336 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.307 0.204 CID_31507 | ||
| 0.208 | 0.044 | 0.208 | Growth factor antagonist | 0.149 0.07 CID_31507 | ||
| 0.193 | 0.038 | 0.193 | Cyclin-dependent kinase 3 inhibitor | 0.19 0.04 CID_31507 | ||
| 0.23 | 0.076 | 0.23 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.185 | 0.032 | 0.185 | Aldehyde dehydrogenase inhibitor | |||
| 0.157 | 0.005 | 0.157 | Cyclin B inhibitor | |||
| 0.181 | 0.033 | 0.181 | Epidermal growth factor receptor kinase inhibitor | 0.125 0.068 CID_31507 | ||
| 0.225 | 0.084 | 0.225 | Dyrk kinase inhibitor | |||
| 0.181 | 0.041 | 0.181 | GABA C receptor rho-2 antagonist | 0.155 0.067 CID_31507 | ||
| 0.165 | 0.04 | 0.165 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.165 | 0.04 | 0.165 | Abl kinase inhibitor | |||
| 0.216 | 0.091 | 0.216 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.211 | 0.089 | 0.211 | Free radical scavenger | |||
| 0.22 | 0.101 | 0.22 | Antioxidant | |||
| 0.116 | 0.005 | 0.116 | Guanylate cyclase stimulant | 0.043 0.031 CID_31507 | ||
| 0.163 | 0.054 | 0.163 | MAO inhibitor | 0.121 0.074 CID_31507 | ||
| 0.15 | 0.046 | 0.15 | Cathepsin H inhibitor | 0.133 0.06 CID_31507 | ||
| 0.207 | 0.11 | 0.235 | Superoxide dismutase inhibitor | 0.235 0.085 CID_31507 | CID_31507 | |
| 0.263 | 0.165 | 0.263 | Antibacterial | 0.228 0.198 CID_31507 | ||
| 0.102 | 0.013 | 0.102 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.048 CID_31507 | ||
| 0.13 | 0.043 | 0.13 | Xanthine oxidase inhibitor | |||
| 0.18 | 0.099 | 0.18 | Histone acetyltransferase inhibitor | 0.169 0.115 CID_31507 | ||
| 0.11 | 0.03 | 0.11 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.141 | 0.061 | 0.141 | c-Src kinase inhibitor | |||
| 0.122 | 0.045 | 0.122 | Carbonic anhydrase XV inhibitor | |||
| 0.15 | 0.074 | 0.15 | Acetylcholine M1 receptor antagonist | |||
| 0.106 | 0.032 | 0.106 | Inducible nitric-oxide synthase inhibitor | |||
| 0.112 | 0.044 | 0.112 | Nitric-oxide synthase inhibitor | |||
| 0.122 | 0.057 | 0.23 | Cyclin-dependent kinase 5 inhibitor | 0.23 0.017 CID_31507 | CID_31507 | |
| 0.117 | 0.052 | 0.167 | Check point kinase 2 inhibitor | 0.167 0.026 CID_31507 | CID_31507 | |
| 0.121 | 0.057 | 0.121 | Cystathionine beta-synthase inhibitor | |||
| 0.177 | 0.114 | 0.177 | 5 Hydroxytryptamine 3E antagonist | 0.166 0.151 CID_31507 | ||
| 0.075 | 0.015 | 0.075 | Lysine-specific demethylase 1A inhibitor | |||
| 0.184 | 0.125 | 0.184 | MAP-kinase-activated kinase 5 inhibitor | 0.17 0.148 CID_31507 | ||
| 0.105 | 0.049 | 0.105 | CDK/cyclin complex inhibitor | |||
| 0.112 | 0.055 | 0.112 | DOPA decarboxylase inhibitor | |||
| 0.108 | 0.052 | 0.108 | GABA C receptor rho-1 antagonist | |||
| 0.064 | 0.009 | 0.064 | Alpha 1d adrenoreceptor agonist | |||
| 0.145 | 0.092 | 0.145 | Heat shock protein 90 alpha antagonist | |||
| 0.141 | 0.088 | 0.141 | Cyclin-dependent kinase 8 inhibitor | 0.135 0.095 CID_31507 | ||
| 0.067 | 0.02 | 0.067 | Thromboxane synthase inhibitor | |||
| 0.05 | 0.005 | 0.05 | Thymidine phosphorylase inhibitor | |||
| 0.066 | 0.023 | 0.066 | Factor IXa inhibitor | 0.059 0.027 CID_31507 | ||
| 0.108 | 0.066 | 0.108 | GABA C receptor antagonist | |||
| 0.176 | 0.135 | 0.176 | Immunostimulant | |||
| 0.102 | 0.065 | 0.102 | GABA C receptor agonist | |||
| 0.073 | 0.037 | 0.115 | Exportin-1 inhibitor | 0.115 0.005 CID_31507 | CID_31507 | |
| 0.104 | 0.071 | 0.104 | 5 Hydroxytryptamine 3A agonist | |||
| 0.174 | 0.142 | 0.174 | Nitric-oxide synthase stimulant | |||
| 0.063 | 0.034 | 0.063 | Botulinum neurotoxin type A inhibitor | 0.063 0.033 CID_31507 | ||
| 0.082 | 0.054 | 0.082 | Carbonic anhydrase VI inhibitor | |||
| 0.074 | 0.05 | 0.074 | Glutamate decarboxylase inhibitor | |||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase VB inhibitor | |||
| 0.083 | 0.062 | 0.083 | mTOR complex 2 inhibitor | |||
| 0.186 | 0.168 | 0.186 | MAP kinase kinase 3 inhibitor | |||
| 0.034 | 0.018 | 0.034 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.12 | 0.108 | 0.12 | Src kinase inhibitor | |||
| 0.058 | 0.048 | 0.058 | CDK1/cyclin B inhibitor | |||
| 0.104 | 0.096 | 0.151 | Alpha-N-acetylglucosaminidase inhibitor | 0.151 0.055 CID_31507 | CID_31507 | |
| 0.151 | 0.146 | 0.151 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.061 | 0.058 | 0.061 | Carbonic anhydrase VA inhibitor | |||
| 0.129 | 0.126 | 0.129 | Ca2+-transporting ATPase inhibitor | |||
| 0.045 | 0.043 | 0.045 | Dopamine beta hydroxylase inhibitor | |||
| 0.083 | 0.081 | 0.083 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.05 | 0.052 | 0.07 | Fatty acid synthase inhibitor | 0.07 0.026 CID_31507 | CID_31507 | |
| 0.059 | 0.07 | 0.077 | Porphobilinogen synthase inhibitor | 0.077 0.049 CID_31507 | CID_31507 | |
| 0.081 | 0.097 | 0.092 | Ferrochelatase inhibitor | 0.092 0.081 CID_31507 | CID_31507 | |
| 0.114 | 0.131 | 0.13 | Thiol protease inhibitor | 0.13 0.097 CID_31507 | CID_31507 | |
| 0.203 | 0.222 | 0.233 | DNA polymerase beta inhibitor | 0.233 0.203 CID_31507 | CID_31507 | |
| 0.086 | 0.122 | 0.118 | CDK3/cyclin E inhibitor | 0.118 0.059 CID_31507 | CID_31507 | |
| 0.091 | 0.133 | 0.112 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.112 0.108 CID_31507 | CID_31507 | |
| 0.03 | 0.092 | 0.047 | GABA A receptor antagonist | 0.047 0.046 CID_31507 | CID_31507 | |
| 0.061 | 0.129 | 0.112 | Falcipain 3 inhibitor | 0.112 0.059 CID_31507 | CID_31507 | |
| 0.034 | 0.11 | 0.069 | Cyclin D1 inhibitor | 0.069 0.03 CID_31507 | CID_31507 | |
| 0.087 | 0.231 | 0.148 | Anticonvulsant | 0.148 0.132 CID_31507 | CID_31507 | |
| 0.021 | 0.205 | 0.076 | Amidase inhibitor | 0.076 0.041 CID_31507 | CID_31507 | |
| 0.012 | 0.593 | 0.073 | Transcription factor AP-1 inhibitor | 0.073 0.027 CID_31507 | CID_31507 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |